Production (Stage)
RTW Biotech Opportunities Ltd
RTWFF
$1.20
$0.010.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 8.19M | 6.67M | 5.16M | 4.66M | 4.17M |
| Total Revenue | 8.19M | 6.67M | 5.16M | 4.66M | 4.17M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 8.19M | 6.67M | 5.16M | 4.66M | 4.17M |
| SG&A Expenses | 11.31M | 9.95M | 8.59M | 7.64M | 6.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.16M | 10.66M | 9.16M | 8.16M | 7.16M |
| Operating Income | -3.97M | -3.99M | -4.00M | -3.50M | -2.99M |
| Income Before Tax | 34.18M | 85.35M | 136.53M | 109.86M | 83.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.18 | 85.35 | 136.53 | 109.86 | 83.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.18M | 85.35M | 136.53M | 109.86M | 83.19M |
| EBIT | -3.97M | -3.99M | -4.00M | -3.50M | -2.99M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.10 | 0.30 | 0.50 | 0.45 | 0.39 |
| Normalized Basic EPS | 0.08 | 0.08 | 0.09 | 0.02 | -0.05 |
| EPS Diluted | 0.10 | 0.30 | 0.50 | 0.45 | 0.39 |
| Normalized Diluted EPS | 0.08 | 0.08 | 0.09 | 0.02 | -0.05 |
| Average Basic Shares Outstanding | 1.34B | 1.22B | 1.09B | 969.37M | 846.05M |
| Average Diluted Shares Outstanding | 1.34B | 1.22B | 1.09B | 969.37M | 846.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |